← Back to Search

Unknown

Lu AG06474 for Healthy Subjects

Phase 1
Waitlist Available
Research Sponsored by H. Lundbeck A/S
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up from pre-dose to day 4
Awards & highlights

Summary

This trial is testing a new drug called Lu AG06474 to see if it is safe and how well people can tolerate it. The study involves healthy volunteers or a general population to understand what happens to the drug in the body after swallowing it. The trial has two parts with different methods to ensure accurate results.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~from pre-dose to day 4
This trial's timeline: 3 weeks for screening, Varies for treatment, and from pre-dose to day 4 for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Part A: t1/2 of Lu AG06474
Parts A and B: AUC0-inf of Lu AG06474
Parts A and B: Cmax of Lu AG06474
+1 more

Trial Design

2Treatment groups
Experimental Treatment
Group I: Part B: Repeated Dose of Lu AG06474 and Food InteractionExperimental Treatment1 Intervention
Participants will receive a single oral dose of Lu AG06474 in each dosing period (Period 1, 2, and 3) in the following sequence: Sequence B1: Fed - Fasting- Fasting Sequence B2: Fasting- Fed - Fasting Sequence B3: Fasting- Fasting - Fed
Group II: Part A: Single Dose of Lu AG06474 or PlaceboExperimental Treatment2 Interventions
Participants will receive single oral dose of Lu AG06474 or placebo.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Placebo
1995
Completed Phase 3
~2670
Lu AG06474
2023
Completed Phase 1
~110

Find a Location

Logistics

Participation is compensated

You will be compensated for participating in this trial.

Who is running the clinical trial?

H. Lundbeck A/SLead Sponsor
329 Previous Clinical Trials
77,591 Total Patients Enrolled
Email contact via H. Lundbeck A/SStudy DirectorH. Lundbeck A/S
189 Previous Clinical Trials
58,211 Total Patients Enrolled
~19 spots leftby Sep 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top